Montelukast Prescribing at PORTSDOWN GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
6,086
Total Quantity
201.4K
NHS Cost
£10.6K
vs National Avg
+788.8%
PORTSDOWN GROUP PRACTICE prescribed 6,086 items of Montelukast over the last 12 months at a cost of £10,625 to the NHS. This is 788.8% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
460
Jun 2026
508
Jun 2026
530
Jun 2026
462
Jun 2026
510
Jun 2026
505
Jun 2026
528
Jun 2026
525
Jun 2026
552
Jun 2026
500
Jun 2026
527
Jun 2026
479
Prescribing Details
| Total Items | 6,086 |
|---|---|
| Total Quantity | 201,393 |
| Total NHS Cost | £10,625 |
| Presentations | 8 different forms |
| vs National Average | +788.8% |
Montelukast Prescribing Comparison
| This practice | 6,086 items |
|---|---|
| National average per practice | 685 items |
| Difference | +788.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.